Answer
When tisotumab vedotin is given with clarithromycin, a strong CYP3A4 inhibitor, caution and close monitoring for adverse reactions are recommended.
Sources for this answer
- TivdakGenmab A/S · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked